NeuroGenesis and Hadassah Medical Center Report Positive NF-L Biomarker Results from a Phase 2 Study in Progressive Multiple Sclerosis Treated with NG-01 Cells Therapy
Ticker Tech,
- Results, published in Stem Cells Translational Medicine, show significant reduction of NF-L, a biomarker for neuronal damage…